Diabetes, Obesity & Metabolism Research

The Studies

Diabetes, obesity, fatty liver disease, and atherosclerosis are among the most common, costly, and preventable of all health problems, and mainly due to dysregulation of lipid, glucose or energy metabolism. Metabolic dysregulation may cause a number of other chronic diseases and conditions. The researchers also aim to build a collaborative internationally-recognized Center of Excellence for fundamental and translational research in diabetes, obesity and metabolism.

The Statistics

30M+

More than 30 million people in the U.S. have diabetes.

By 2030, non-alcoholic steatohepatitis, will be the #1 reason for liver transplants in the U.S.

39.8%

In 2015-16, 39.8% of adults in the U.S. were affected by obesity.

The Successes

Uncovered novel pathogenic mechanisms of NAFLD and atherosclerosis
Identified novel targets for treatment of NAFLD, atherosclerosis, and obesity
Identified novel mechanisms of bile acid regulation

Discovered novel roles that non-lipid factors play in vessel blockage
Dr. Chiang is a recipient of a prestigious Merit Award from NIDDK

The Scientists

Researchers within this area have expertise in studying bile acid, glucose, lipid and lipoprotein metabolism.

Our Research

The Stories

Students Participate in NIH Programs

Two medicine students from Northeast Ohio Medical University participated in the 2018 National Institute of Diabetes and Digestive and Kidney […]

Read the Story
Students Present at National Symposium

A symposium held in Santa Fe, New Mexico, was the destination recently for two Northeast Ohio Medical School students who […]

Read the Story
Liver disease findings published in Molecular & Cellular Proteomics journal

A paper by Kwangwon Lee, Ph.D., and a team of NEOMED researchers in the lab of Takhar Kasumov, Ph.D., has […]

Read the Story